Australia: GSK, MMV filing for Kozenis (tafenoquine) in pediatric populations accepted
by Press Release from Outbreak News Today on (#5CKDK)
GSK and Medicines for Malaria Venture (MMV) announced today that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the indication of single-dose Kozenis (tafenoquine) to paediatric populations for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria. The application includes data for a new, 50 [...]
The post Australia: GSK, MMV filing for Kozenis (tafenoquine) in pediatric populations accepted appeared first on Outbreak News Today.